TScan Therapeutics, Inc. (NASDAQ:TCRX) Financings
Financings
| Raise | Date |
|---|---|
| Registered direct offering of pre-funded warrants Announced: about US$30M · US$4 a share · Warrants at US$0.0001 Buyers: Lynx1 Capital Management LP (with an investment fund advised by Lynx1, buying approximately $30 million of pre-funded warrants) Use of proceeds: Extend cash runway to fund operations into the first quarter of 2027 | Dec 26, 2024 |